FINHUB Insights

ZTS · Q2 FY26 · Apr 1 – Jun 30, 2026

Zoetis Q2 FY26: where the revenue came from and where it went

Zoetis Q2 FY26: revenue $2.5B (+0% year over year). Net profit $0.7B. Largest cohort Livestock $0.7B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
Aug 6, 2026 10-Q
Sankey diagram of Zoetis's income statement for Q2 FY26: revenue of $2.47 billion splits into segments and flows out into costs, taxes and net profit.
100% free

It's free. All of it.

Create a free account and every diagram unlocks. All we ask for is your email.

Continue with Google Create a free account

Already have an account? Sign in

Revenue$2.47B +0% year over year
Gross profit$1.80B 73% margin
Operating profit$0.86B 35% margin
Net profit$0.69B 28% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 2.47 100% +0%
Livestock 0.73 30%
Dermatology 0.40 16%
Cattle 0.39 16%
Other 0.32 13%
Pain sedation 0.22 9%
Other pharmaceuticals 0.17 7%
Animal health diagnostics 0.12 5%
Swine 0.12 5%
Cost of revenue−0.6727%
Gross profit1.8073% margin+0pp
SG&A−0.5924%−1pp
Other−0.3414%+0pp
Operating profit0.8635% margin−2pp
Tax−0.17
Net profit0.6928%−1pp
Filing on EDGAR More quarters of ZTS

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.